Table 1. Clinical characteristics of each patient and intraprostatic lesion (IPL).
Patient | Gleason score | Clinical stage | PSA prior to biopsy | Previous biopsies |
---|---|---|---|---|
1 | 3 + 3 = 6 | T1c | 4.1 | 0 |
2 | 3 + 3 = 6 | T2a | 2.95 | 1 |
3a | 3 + 3 = 6 | T1c | 5.17 | 1 |
3b | 3 + 3 = 6 | T1c | 5.17 | 1 |
4 | 3 + 3 = 6 | T1c | 6 | 1 |
5 | 3 + 3 = 6 | T1c | 4.5 | 0 |
6 | 3 + 3 = 6 | T1c | 5 | 4 |
7 | 4 + 4 = 8 | T1c | 9 | 2 |
8 | 4 + 4 = 8 | T1c | 5.1 | 1 |
9 | 4 + 5 = 9 | T1c | 15.2 | 4 |
10 | 4 + 5 = 9 | T1c | 9.02 | 2 |
11 | 5 + 5 = 10 | T1c | 6.19 | 0 |